RESEARCH TRIANGLE PARK, N.C., Feb 10, 2010 (BUSINESS WIRE) -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced today
that its Board of Directors established March 11, 2010 as the record
date for determining stockholders entitled to vote at the 2010 Annual
Meeting of Stockholders. The annual meeting will be held on April 20,
2010 at 9:00 AM Eastern Time at The Carolina Inn, 211 Pittsboro Street
in Chapel Hill, North Carolina.
About Talecris Biotherapeutics: Inspiration. Dedication.
Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology
company that discovers, develops and produces critical care treatments
for people with life-threatening disorders in a variety of therapeutic
areas including immunology, pulmonology, neurology and hemostasis. For
more information, please visit: www.talecris.com.
SOURCE: Talecris Biotherapeutics Holdings Corp.
Talecris Investor Relations
Drayton Virkler, 919-316-2356
drayton.virkler@talecris.com
or
Talecris Corporate Communications
Becky Levine, 919-316-6590
becky.levine@talecris.com
